share_log

HC Wainwright & Co. Downgrades Mainz Biomed to Neutral

Benzinga ·  Nov 25 06:59

HC Wainwright & Co. analyst Yi Chen downgrades Mainz Biomed (NASDAQ:MYNZ) from Buy to Neutral.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment